Intrinsiqq
Cnbx Pharmaceuticals Inc. logo

Cnbx Pharmaceuticals Inc.

CNBX

Compare
⚠ Showing the latest available close (Nov 19, 2026, 3 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$161K
EPS$0.00
P/E0.10
P/FCF–
EV/EBITDA-0.63
FCF Yield–
Div. Yield–
Net Debt/FCF–
Cnbx Pharmaceuticals Inc. intrinsic value
52-Week Range
$0.00$0.00

Profitability & Returns

Revenue (TTM)

$0.00

▼ -100.0% YoY

Net Income (TTM)

-$462K

▲ +54.8% YoY

Op. Margin

–

ROIC

-695.94%

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$154K

▲ +29.9% YoY

Net Debt

$111K

Cash & Equiv.

$9K

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with CNBX

CompareIntrinsic value
ENVBEnveric Biosciences Inc.
$1.35-4.26%21
LNAILunai Bioworks Inc.
No recent price10
NRIXNurix Therapeutics Inc.
$12.85-5.51%84
MNKDMannKind Corporation
$3.85-2.53%30
SYBXSynlogic Inc.
$0.96+0.02%20
MTNBMatinas Biopharma Holdings Inc.
$0.80-1.23%40
XBIOXenetic Biosciences Inc.
$1.40-9.09%40
CPHIChina Pharma Holdings Inc.
$0.44-12.32%25

Cnbx Pharmaceuticals (CNBX) in three numbers

Quality score
10/100
Best check: share count change, 107748.0%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
0.10
From the last twelve months of earnings.
Financials

Questions about Cnbx Pharmaceuticals

Is Cnbx Pharmaceuticals (CNBX) overvalued?

Cnbx Pharmaceuticals trades at 0.10 times earnings. Intrinsiqq's fair value calculator has no opening value for CNBX, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.

Is Cnbx Pharmaceuticals a high-quality business?

Cnbx Pharmaceuticals scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from SEC filings. Its best check is share count change at 107748.0%. The Quality tab shows every check against its target.

Does Cnbx Pharmaceuticals (CNBX) pay a dividend?

No. Cnbx Pharmaceuticals (CNBX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 17 Jun 2026 (period ending 31 May 2026), SEC. Price: last close 19 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in CNBX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CNBX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.